Home/Health Plans/Employers/OnTrak Members/Contact Us
/
         
Blog Home  
  » Home  
  Recent Posts  
 
 
 
  Blog Calendar  
 
SuMoTuWeThFrSa
  
1
2345
6
7
8
9
10
1112
13141516171819
20212223242526
2728293031  
 
  Archive  
 
 
  Catasys Newsletter  
  Get the latest in healtcare news. » Sign Up Now  

Welcome to the Catasys On Healthcare Blog
Substance dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly. Stay informed on these topics by visiting our blog periodically. You can also sign up for the Catasys On Healthcare Newsletter to receive the latest in health care news. » Sign Up for Newsletter


Raymond Anton, Medical University of South Carolina, Charleston, SC

Catasys Health - Saturday, August 01, 2009

Randomized, Stratified, Double-Blind, Placebo-Controlled Trial of Flumazenil and Gabapentin for the Treatment of Alcohol Dependence
Published in the Journal of Clinical Psychopharmacology, August 2009; 29(4):334-342.

 The OnTrak Medical Treatment Program achieved a significant reduction in use and cravings among members with symptoms of alcohol withdrawal (>6 CIWA) when compared to placebo.

Among members with more symptoms of alcohol withdrawal, the Prometa group experienced: ยป More



Comments (0) | Trackbacks (0) | Permalink


| 1 |

 
 
  Tags
 
substance dependence health insurance dependence issues over-the-counter substances behavioral healthcare diabetes hydrocodone methamphetamine reduction in use drug treatment health insurance health plan vivitrol Journal of Psychopharmacology drug addicts smoking codeine CIWA stratified addiction facebook mental illness reducing craving binge drinking painkillers Research Across America withdrawal drug addiction naloxone Health Care Utilization pain killers bipolar disorder medical and behavioral costs relapse prevention heroin substance dependence costs placebo-controlled opioid abuse fentanyl ADHD substance dependence opiod abuse opiod-based addiction treatment predictive modeling hospitalizations double-blind communication prometa overdose drug use buprenorphine methamphetamine dependence medical costs addict trauma contract Co Occurring Disorders ADD alcohol treatment recovery network health reform PTSD substance use disorder Raymond Anton hospital suboxone post-traumatic stress disorder UnitedHealthcare marijuana sobriety urine drug screen prescriptions anxiety drinking cocaine placebo cocaine treatment opioid overdose morphine behavioral health care cigarettes muscle relaxant social network drug abuse craving score SD members OxyContin opiates alcoholism identification alcohol nicotine randomized Opioid Treatment craving behavioral health flumazenil relapse data mining SD health insurance OnTrak mental health opioid-drug interactions Opioid Medications stimulants physician- patient relations care coaching medical stress methadone behavioral health care services high-utilizing reduction in craving Harold Urschel treatment depression chronic pain narcotic vicodin alcohol dependence alcohol drinking pain medication emergency room opioid gabapentin psychosocial behavioral healthcare services opioid antagonist Catasys primary care ER oxycodone percocet sugar depression screening pain pills sober recovery meth
  Call Us Today
  866-517-1414
         
 
 
Home/News/Press/Investor Relations/Careers/BlogContact Us/Site Index/Privacy Policy
 
  Copyright © 2011 Catasys. All rights reserved. | 11150 Santa Monica Blvd., Suite 1500, Los Angeles, California 90025